Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain

Schizophrenia Bulletin

Volumn 24, Issue 2, 1998, Pages 219-230

  Benes, Francine M ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Brain; Cingulate cortex; Circuitry

Indexed keywords

AUTOPSY; CINGULATE GYRUS; GABAERGIC SYSTEM; HUMAN; NERVE CELL NETWORK; NERVE PROJECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0031781132     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033322     Document Type: Review

References (70)

1. Akbarian, S.; Kim, J.J.; Potkin, S.G.; Hagman, J.O.; Tafazzoli, A.; Bunney, W.E.; and Jones, E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry, 52:258-266, 1995.
2. Akil, M., and Lewis, D.A. The dopaminergic innervation of monkey entorhinal cortex. Cerebral Cortex, 3:533-550, 1993.
3. Akil, M., and Lewis, D.A. The catecholaminergic innervation of the human entorhinal cortex:Alterations in schizophrenia. [Abstract] Society for Neuroscience Abstracts, 21:98.10, 1995.
4. Arnold, S.E.; Franz, B.R.; Gur, R.C.; Gur, R.E.; Shapiro, R.M.; Moberg, P.J.; and Trojanowski, J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. American Journal of Psychiatry, 152:738-748, 1995.
5. Benes, F.M. Post-mortem structural analyses of schizophrenic brain: Study designs and the interpretation of data. Psychiatric Developments, 6:213-226, 1988.
6. Benes, F.M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophrenia Bulletin, 19(3):537-549, 1993a.
7. Benes, F.M. The relationship between structural brain imaging and histopathologic findings in schizophrenia research. Harvard Review of Psychiatry, 1:100-109, 1993b.
8. Benes, P.M. The relationship of cingulate cortex to schizophrenia. In: Vogt, B.A., and Gabriel, M., eds. Neurobiology of Cingulate Cortex and Limbic Thalamus. Boston, MA: Birkhäuser, 1993c. pp. 581-605.
9. Benes, P.M. Is there a neuroanatomic basis for schizophrenia? The Neuroscientist, 1:112-120, 1995.
10. Benes, P.M. Excitotoxicity in the development of corticolimbic alterations in schizophrenic brain. In: Watson, S.J., ed. Biology of Schizophrenia and Affective Disease. Washington, DC:American Psychiatric Press, 1996a. pp. 83-111.
11. Benes, P.M. The role of glutamate in the pathophysiology of schizophrenia. In:Conti, P., and Hicks, T.P., eds. Excitatory Amino Acids and the Cerebral Cortex. Cambridge, MA:MIT Press, 1996b. pp. 361-374.
12. Benes, P.M., and Bird, E.D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Archives of General Psychiatry, 44:608-616, 1987.
13. Benes, P.M.; Davidson, J.; and Bird, E.D. Quantitative cytoarchitectural studies of cerebral cortex of schizophrenics. Archives of General Psychiatry, 43:31-35, 1986.
14. Benes, P.M.; Khan, Y.; Vincent, S.L.; and Wickramasinghe, R. Differences in the subregional and cellular distribution of GABA-A receptor binding in the hippocampal formation of schizophrenic brain. Synapse, 22:338-349, 1996a.
15. Benes, P.M.; Majocha, R.; Bird, E.D.; and Marrotta, C.A. Increased vertical axon numbers in cingulate cortex of schizophrenics. Archives of General Psychiatry, 44:1017-1021, 1987.
16. Benes, F.M.; McSparren, J.; Bird, E.D.; Vincent, S.L.; and SanGiovanni, J.P. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients. Archives of General Psychiatry, 48:996-1001, 1991a.
17. Benes, P.M.; Sorensen, I.; and Bird, E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophrenia Bulletin, 17(4):597-608, 1991b.
18. Benes, F.M.; Sorensen, I.; Vincent, S.L.; Bird, E.D.; and Sathi, M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cerebral Cortex, 2:502-512, 1992a.
19. Benes, F.M.; Todtenkopf, M.S.; and Taylor, J.B. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse, 25(1):80-92, 1997a.
20. Benes, F.M.; Vincent, S.L.; Alsterberg, G.; Bird, E.D.; and SanGiovanni, J.P. Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience, 12:924-929, 1992b.
21. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience, 75(4):1021-1031, 1996b.
22. Benes, P.M.; Vincent, S.L.; and Molloy, R. Dopamine-immunoreactive axon varicosities form nonrandom contacts with GABA-immunoreactive neurons in rat medial prefrontal cortex. Synapse, 15:285-295, 1993.
23. Benes, P.M.; Vincent, S.L.; Molloy, R.; and Khan, Y. Increased interaction of dopamine-immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the post-weaning period. Synapse, 23:237-245, 1996c.
24. Benes, F.M.; Vincent, S.L.; and San Giovanni, J.P. High resolution imaging of receptor binding in analyzing neuropsychiatric diseases. Biotechniques, 7:970-979, 1989.
25. A and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain. Brain Research, 755(1):121-129, 1997b.
26. Bird, E.D.; Barnes, J.; Iversen, L.; Spokes, E.G.; Mackay, A.V.P.; and Shepherd, M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyltransferase activity in schizophrenia and related psychoses. Lancet, 1:1157-1159, 1977.
27. Colon, E.J. Quantitative cytoarchitectonics of the human cerebral cortex. Psychiatria, Neurologia, Neurochirurgia, 74:291-302, 1971.
28. Dom, R. "Neostriatal and Thalamic Interneurons:Their Role in the Pathophysiology of Huntington's Chorea, Parkinson's Disease, and Catatonic Schizophrenia." Unpublished dissertation, Katholieke Universiteit Leuven, Leuven, Belgium, 1976.
29. Falkai, P., and Bogerts, B. Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry and Neurological Science, 236:154-161, 1986.
30. Falkai, P.; Bogerts, B.; and Rozumek, M. Limbic pathology in schizophrenia:The entorhinal region - A morphometric study. Biological Psychiatry, 24:515-521, 1988.
31. Farber, N.B.; Wozniak, D.F.; Price, M.T.; Labruyere, J.; Huss, J.; St. Peter, H.; and Olney, J. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade:Potential relevance to schizophrenia? Biological Psychiatry, 38:783-787, 1995.
32. Caspar, P.; Berger, B.; Febvret, A.; Vigny, A.; and Henry, J.P. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. Journal of Comparative Neurology, 279:249-271, 1989.
33. Gellman, R.L., and Aghajanian, G.K. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Research, 600:63-73, 1993.
34. Goldman-Rakic, P.S.; Leranth, C.; Williams, S.M.; Mons, N.; and Geffard, M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America, 86:9015-9019, 1989.
35. 3H-Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sciences, 40:259-266, 1987.
36. Heckers, S.; Heinsen, H.; Geiger, B.; and Beckmann, H. Hippocampal neuron number in schizophrenia. Archives of General Psychiatry, 48:1002-1008, 1991.
37. Henn, R.A., and McKinney, W.T. Animal models in psychiatry. In:Meltzer, H.Y., ed. Psychopharmacology:The Third Generation. New York, NY:Raven Press, 1987. pp. 687-695.
38. Huntley, G.W.; Morrison, J.H.; Prikhozhan, A.; and Sealfon, S.C. Localization of multiple dopamine receptor subtypes mRNAs in human and monkey motor cortex and striatum. Molecular Brain Research, 15:181-188, 1992.
39. Jakob, H., and Beckmann, H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65:303-326, 1986.
40. Jeste, D., and Lohr, J.B. Hippocampal pathologic findings in schizophrenia. Archives of General Psychiatry, 46:1019-1024, 1989.
41. Jones, E.G. GABA-peptide neurons in primate cerebral cortex. Journal of Mind Behavior, 8:519-536, 1987.
42. Kety, S. Biochemical theories of schizophrenia:Part II. Current theories and the evidence used to support them. Science, 129:1590-1596, 1959.
43. Kovelman, J.A., and Scheibel, A.B. A neurohistological correlate of schizophrenia. Biological Psychiatry, 19:1601-1621, 1984.
44. Kraepelin, E. Dementia Praecox and Paraphrenia. (1919) Translated by R.M. Barclay. Edinburgh, Scotland:E. and S. Livingstone, 1921.
45. Lewis, D.A.; Campbell, M.J.; Foote, S.L.; Goldstein, M.; and Morrison, J.H. The distribution of tyrosine hydroxylase immunoreactive fibers in primate neocortex is widespread but regionally specific. Journal of Neuroscience, 7:279-290, 1987.
46. Meltzer, H.Y.; Matsubara, S.; and Lee, J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2, and serotonin-2 pKi values. Journal of Pharmacology and Experimental Reviews, 43:587-604, 1989.
47. Noack, H.J., and Lewis, D.A. Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex. Brain Research, 500:313-324, 1989.
48. Olney, J.W., and Farber, N.B. Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry, 52:998-1007, 1995.
49. Pakkenberg, B. Post-mortem study of chronic schizophrenic brains. British Journal of Psychiatry, 151:744-752, 1987.
50. Pakkenberg, B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical dissectors. Biological Psychiatry, 34:768-772, 1993.
51. 3H]aminobutyrique induite electriquement dans le cortex prefrontal du rat. Comtes Rendus de l'Academic des Sciences, 309:441-444, 1989.
52. Perry, T.L.; Buchanan, J.; Kish, S.J.; and Hansen, S. Gamma-aminobutyric acid deficiency in brains of schizophrenic patients. Lancet, 1:237-239, 1979.
53. Pope, H.G. Neuroglia; Quantitative aspects. In:Schoffeniels, E., ed. Dynamic Properties of Glial Cells. New York, NY:Pergamon Press, 1978. pp. 13-20.
54. 3H]GABA on rat prefrontal cortex slices. Neuroscience, 42:61-71, 1991a.
55. 3H]GABA in the rat prefrontal cortex. Neuroscience, 43:323-329, 1991b.
56. Reynolds, G.P.; Czudek, C.; and Andrews, H. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biological Psychiatry, 27:1038-1044, 1990.
57. Roberts, E. An hypothesis suggesting that there is a defect in the GABA system in schizophrenia. Neurosciences Research Program Bulletin, 10:468-482, 1972.
58. Samson, Y.; Wu, J.J.; Friedman, A.H.; and Davis, J.N. Catecholaminergic innervation of the hippocampus in the cynomolgus monkey. Journal of Comparative Neurology, 298:250-263, 1990.
59. Seguela, P.; Watkins, K.C.; and Descarries, L. Ultrastructural features of dopamine axon terminals in the anteromedial and suprarhinal cortex of rat. Journal of Comparative Neurology, 289:11-22, 1988.
60. Selemon, L.D.; Rajkowska, G.; and Goldman-Rakic, P.S. Abnormally high neuronal density in the schizophrenic cortex:A morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry, 52:805-818, 1995.
61. Simpson, M.D.; Slater, P.; Deakin, J.F.; Royston, M.C.; and Skan, W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neuroscience Letters, 107:211-215, 1989.
62. Squires, R.F.; Lajtha, A.; Saederup, E.; and Palkovits, M. Reduced [3-H]-Flunitrazepam bindings in cingulate cortex and hippocampus of postmortem schizophrenic brains. Neurochemical Research, 18:219-223, 1993.
63. Verney, C.; Alvarez, C.; Gerrard, M.; and Berger, B. Ultrastructural double-labelling study of dopamine terminals and GABA-containing neurons in rat anteromedial cortex. European Journal of Neuroscience, 2:960-972, 1991.
64. Vincent, S.L.; Adamec, E.; Sorensen, I.; and Benes, F.M. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse, 17:26-35, 1994.
65. 2 receptors in rat medial prefrontal cortex. Journal of Neuroscience, 13:2551-2564, 1993.
66. 2 receptors in rat medial prefrontal cortex. Synapse, 19:112-120, 1995.
67. Vincent, S.L.; Todtenkopf, M.S.; and Benes, F.M. A comparison of the density of pyramidal (PN) and nonpyramidal (NP) neurons in anterior cingulate cortex of schizophrenics and manic depressives. [Abstract] Abstracts of the Society for Neuroscience, 23:2199, 1997.
68. Wiebel, E.R. Elementary introduction to stereological principles. In:Stereological Methods. New York, NY:Academic Press, 1979a. pp. 46-57.
69. Wiebel, E.R. Practical methods for biological morphometry. In:Stereological Methods. New York, NY:Academic Press, 1979b.
70. Williams, S.M., and Goldman-Rakic, P.S. Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody. Cerebral Cortex, 3:199-222, 1993.